Comparing two hormone stimulation methods for IVF treatment
Part of Women’s health & pregnancy clinical trials.
This study compares two ways of giving fertility medication to stimulate the ovaries before retrieving eggs for IVF (in vitro fertilization). One method starts after ovulation and uses a drug called Elonva without a routine blocking medication, while the other is the standard approach starting early in the cycle. The goal is to see which approach leads to better outcomes for people undergoing IVF or ICSI (a procedure where a single sperm is injected into an egg).
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 38 years old.
- Your menstrual cycles are regular, lasting 25 to 35 days.
- You weigh between 60 and 90 kg (about 132 to 198 pounds).
- Your AMH level (a hormone that shows egg supply) is between 1.3 and 3 ng/mL.
- You have not been diagnosed with PCOS, moderate to severe endometriosis, or endometrioma.
- Your partner has not been diagnosed with azoospermia (no sperm in the semen).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two methods of stimulating the ovaries before IVF: one using a standard hormone (hCG) and another using a different protocol. The goal is to see if the new method works as well as the standard one, while possibly being more cost-effective.
This study tests whether changing the timing of hormones during ovarian stimulation can improve IVF results for people with certain ovarian reserve levels. It may help find a stimulation approach that works better for first-time (or second) IVF cycles.
This study compares two fertility medications (rFSH and hMG) to see how they affect the cells around your eggs and the quality of embryos. It may help you and your doctor choose the best stimulation drug for your IVF cycle.
This study looks at whether tracking a hormone called FSH during ovarian stimulation can help find the best level for egg development. It may help improve your chances in fertility treatment.
This trial compares two doses of follicle-stimulating hormone (FSH) to find out which dose helps women with normal ovarian reserve have better IVF outcomes. It aims to improve the chances of a successful pregnancy.
This trial compares two different ways of stimulating the ovaries in women who have a poor response to fertility treatment. It aims to see which method gives a higher chance of having a live baby.
Hear when a new Stimulation in the Ovary trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.